These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20433045)

  • 1. Wyeth v Levine: implications for public health policy and practice.
    David S; Rosenbaum S
    Public Health Rep; 2010; 125(3):494-7. PubMed ID: 20433045
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in health law. Wyeth v. Levine: challenging implied pre-emption for drugs.
    Nair P
    J Law Med Ethics; 2009; 37(3):527-30. PubMed ID: 19791315
    [No Abstract]   [Full Text] [Related]  

  • 3. Good law from tragic facts--Congress, the FDA, and preemption.
    Annas GJ
    N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
    [No Abstract]   [Full Text] [Related]  

  • 4. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS; Studdert DM
    N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warning signs.
    Nature; 2008 Mar; 452(7185):254. PubMed ID: 18354433
    [No Abstract]   [Full Text] [Related]  

  • 7. The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation.
    Morten CJ; Kesselheim AS; Ross JS
    J Law Med Ethics; 2019 Dec; 47(4):783-787. PubMed ID: 31957583
    [No Abstract]   [Full Text] [Related]  

  • 8. How the FDA can overturn Wyeth v. Levine.
    Gostanian A
    Am J Law Med; 2010; 36(1):248-68. PubMed ID: 20481407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supreme Court rules Wyeth's Phenergan warnings were inadequate.
    Lavine G
    Am J Health Syst Pharm; 2009 Apr; 66(8):698, 700. PubMed ID: 19336826
    [No Abstract]   [Full Text] [Related]  

  • 10. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 11. Preemption and malpractice liability.
    Hauser RG
    N Engl J Med; 2009 May; 360(21):2257-8; author reply 2258. PubMed ID: 19458378
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels.
    Boumil MM; Curfman G
    JAMA; 2018 Aug; 320(6):547-548. PubMed ID: 30039167
    [No Abstract]   [Full Text] [Related]  

  • 13. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
    Surprenant JA
    Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two masters.
    Schneider CE
    Hastings Cent Rep; 2010; 40(1):9-10. PubMed ID: 20166509
    [No Abstract]   [Full Text] [Related]  

  • 15. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J
    Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 18. The National Childhood Vaccine Injury Act and the supreme court's interpretation.
    Blake V
    Virtual Mentor; 2012 Jan; 14(1):31-4. PubMed ID: 23116914
    [No Abstract]   [Full Text] [Related]  

  • 19. Product liability and prescription diet drug cocktail, Fen-Phen: a hard combination to swallow.
    Crisanti CA
    J Contemp Health Law Policy; 1998; 15(1):207-44. PubMed ID: 9988998
    [No Abstract]   [Full Text] [Related]  

  • 20. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.